Platelet and Monocyte Microvesicles as Potential Biomarkers of COVID-19 Severity: A Cross-Sectional Analysis
Description
CONCLUSIONS: PMV PMVCD42b^(+) and PMVCD41a^(+) counts were significantly increased in patients with severe clinical symptoms, and PMVCD41a^(+) counts correlated with D-dimer levels. Therefore, MV counts can be used as a potential biomarker of COVID
